Jiajoyce Richardson
Family · Harrisburg, PANPI 1053449504
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Gilead accounts for 93.3% of it on its own, with 28 other manufacturers making up the rest. Among family clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 148 payments — averaging $286.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$40K
- AbbVie$967
- AstraZeneca$505
- Pharmacyclics LLC, An Abbvie Company$180
- Astellas Pharma US Inc$149
- Sanofi$126
- plus $907 from 23 others
What the payments were for
- Consulting fees$1,2503%
- Speaking & faculty fees$21,55851%
- Travel & lodging$16,22738%
- Food & beverage$3,1107%
- Education$2741%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 75 | $39,585 |
| AbbVie | 6 | $967 |
| AstraZeneca | 6 | $505 |
| Pharmacyclics LLC, An Abbvie Company | 9 | $180 |
| Astellas Pharma US Inc | 3 | $149 |
| Sanofi | 3 | $126 |
| Beone Medicines USA, Inc. | 1 | $123 |
| Johnson & Johnson(2 entities) | 9 | $117 |
| E.r. Squibb & Sons, L.L.C. | 1 | $94 |
| Sobi, Inc | 1 | $85 |
| Beigene USA, Inc. | 3 | $53 |
| Bayer | 4 | $50 |
| Fresenius Kabi USA, LLC | 2 | $48 |
| Global Blood Therapeutics, Inc. | 3 | $45 |
| Daiichi Sankyo Inc. | 3 | $38 |
| Rigel Pharmaceuticals, Inc. | 3 | $32 |
| Bristol Myers Squibb | 2 | $31 |
| Agios Pharmaceuticals, Inc. | 1 | $25 |
| EMD Serono, Inc. | 2 | $24 |
| AVEO Pharmaceuticals, Inc. | 2 | $24 |
| Morphosys, US Inc. | 1 | $19 |
| Array Biopharma Inc | 1 | $16 |
| ADC Therapeutics America, Inc. | 1 | $13 |
| EUSA Pharma (US) LLC | 1 | $12 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| Acrotech Biopharma Inc. | 1 | $12 |
| Tersera Therapeutics LLC | 1 | $12 |
| Seagen Inc. | 1 | $11 |
| Janssen Scientific Affairs, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$42,419 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $10,875 |
| Anastrozole | 14 | $231 |
| Dexamethasone | 17 | $160 |
| Prochlorperazine Maleate | 13 | $97 |
| Ondansetron Hcl | 20 | $88 |
Paid to pharmacies, not to this prescriber.
Other family in Harrisburg
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
- Patricia HabdasPittsburgh$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.